Quinolizidine alkaloids reduced mortality in EV71-infected mice by compensating for the levels of T cells

Bioorg Med Chem Lett. 2015 Sep 1;25(17):3526-8. doi: 10.1016/j.bmcl.2015.06.097. Epub 2015 Jul 7.

Abstract

Recent outbreak of hand, foot and mouse disease caused by enterovirus 71 is a serious threat to infants and children in Asia-Pacific countries. No vaccines or antiviral therapies are available against this infection. In this study, we found that quinolizidine alkaloids could improve the levels of T cells in mice. The structure-activity relationships demonstrated that the oxidation and double bonds are important for the excellent potency. Oxysophocarpine, the most effective compound of six quinolizidine alkaloids, could also relieve symptoms and reduce mortality in lethal enterovirus 71-infected mice through compensating for the decreased levels of T cells. This work suggested that quinolizidine alkaloids have the potential against enterovirus 71 for further development of novel antiviral drugs.

Keywords: Enterovirus 71; Hand, foot and mouth disease; Quinolizidine alkaloids; T cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaloids / chemistry
  • Alkaloids / therapeutic use*
  • Animals
  • Antiviral Agents / chemistry
  • Antiviral Agents / therapeutic use*
  • Enterovirus A, Human / drug effects*
  • Enterovirus A, Human / immunology
  • Hand, Foot and Mouth Disease / drug therapy*
  • Hand, Foot and Mouth Disease / immunology
  • Humans
  • Mice, Inbred BALB C
  • Quinolizidines / chemistry
  • Quinolizidines / therapeutic use*
  • Structure-Activity Relationship
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / immunology
  • T-Lymphocytes / virology

Substances

  • Alkaloids
  • Antiviral Agents
  • Quinolizidines
  • oxysophocarpine